348 related articles for article (PubMed ID: 14966739)
1. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
[TBL] [Abstract][Full Text] [Related]
2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
3. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
Sasaki F; Matsunaga T; Iwafuchi M; Hayashi Y; Ohkawa H; Ohira M; Okamatsu T; Sugito T; Tsuchida Y; Toyosaka A; Nagahara N; Nishihira H; Hata Y; Uchino J; Misugi K; Ohnuma N;
J Pediatr Surg; 2002 Jun; 37(6):851-6. PubMed ID: 12037748
[TBL] [Abstract][Full Text] [Related]
4. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
Hishiki T; Matsunaga T; Sasaki F; Yano M; Ida K; Horie H; Kondo S; Watanabe K; Oue T; Tajiri T; Kamimatsuse A; Ohnuma N; Hiyama E
Pediatr Surg Int; 2011 Jan; 27(1):1-8. PubMed ID: 20922397
[TBL] [Abstract][Full Text] [Related]
5. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Hiyama E; Hishiki T; Watanabe K; Ida K; Yano M; Oue T; Iehara T; Hoshino K; Koh K; Tanaka Y; Kurihara S; Ueda Y; Onitake Y
J Pediatr Surg; 2016 Dec; 51(12):2053-2057. PubMed ID: 27712887
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
[TBL] [Abstract][Full Text] [Related]
7. Surgical strategies for unresectable hepatoblastomas.
Tajiri T; Kimura O; Fumino S; Furukawa T; Iehara T; Souzaki R; Kinoshita Y; Koga Y; Suminoe A; Hara T; Kohashi K; Oda Y; Hishiki T; Hosoi H; Hiyama E; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2194-8. PubMed ID: 23217875
[TBL] [Abstract][Full Text] [Related]
8. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol.
Hiyama E; Hishiki T; Watanabe K; Ida K; Ueda Y; Kurihara S; Yano M; Hoshino K; Yokoi A; Takama Y; Nogami Y; Taguchi T; Mori M; Kihira K; Miyazaki O; Fuji H; Honda S; Iehara T; Kazama T; Fujimura J; Tanaka Y; Inoue T; Tajiri T; Kondo S; Oue T; Yoshimura K
J Clin Oncol; 2020 Aug; 38(22):2488-2498. PubMed ID: 32421442
[TBL] [Abstract][Full Text] [Related]
9. Hepatoblastoma--evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases.
Davies JQ; de la Hall PM; Kaschula RO; Sinclair-Smith CC; Hartley P; Rode H; Millar AJ
J Pediatr Surg; 2004 Sep; 39(9):1321-7. PubMed ID: 15359384
[TBL] [Abstract][Full Text] [Related]
10. Mortality and morbidity in primarily resected hepatoblastomas in Japan: Experience of the JPLT (Japanese Study Group for Pediatric Liver Tumor) trials.
Hiyama E; Hishiki T; Watanabe K; Ida K; Yano M; Oue T; Iehara T; Hoshino K; Koh K; Tanaka Y; Kurihara S; Ueda Y; Onitake Y
J Pediatr Surg; 2015 Dec; 50(12):2098-101. PubMed ID: 26388131
[TBL] [Abstract][Full Text] [Related]
11. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
Sunil BJ; Palaniappan R; Venkitaraman B; Ranganathan R
J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
[TBL] [Abstract][Full Text] [Related]
12. Avoiding liver transplantation in post-treatment extent of disease III and IV hepatoblastoma.
El-Gendi A; Fadel S; El-Shafei M; Shawky A
Pediatr Int; 2018 Sep; 60(9):862-868. PubMed ID: 29906299
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
Ortega JA; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Finegold MJ; Haas JE; King DR; Liu-Mares W; Sensel MG; Krailo MD
J Clin Oncol; 2000 Jul; 18(14):2665-75. PubMed ID: 10894865
[TBL] [Abstract][Full Text] [Related]
14. The Role Of Surgical Treatment In The Multidisciplinary Therapy For Hepatoblastoma.
Yada K; Ishibashi H; Mori H; Sato H; Shimada M
Hepatogastroenterology; 2014 May; 61(131):553-6. PubMed ID: 26176034
[TBL] [Abstract][Full Text] [Related]
15. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.
Ismail H; Broniszczak D; Kaliciński P; Dembowska-Bagińska B; Perek D; Teisseyre J; Kluge P; Kościesza A; Lembas A; Markiewicz M
J Pediatr Surg; 2012 Jul; 47(7):1331-9. PubMed ID: 22813792
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatoblastoma: less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin.
Seo T; Ando H; Watanabe Y; Harada T; Ito F; Kaneko K; Horibe K; Sugito T; Ito T
Surgery; 1998 Apr; 123(4):407-14. PubMed ID: 9551066
[TBL] [Abstract][Full Text] [Related]
17. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89.
von Schweinitz D; Hecker H; Harms D; Bode U; Weinel P; Bürger D; Erttmann R; Mildenberger H
J Pediatr Surg; 1995 Jun; 30(6):845-52. PubMed ID: 7545228
[TBL] [Abstract][Full Text] [Related]
18. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.
Venkatramani R; Stein JE; Sapra A; Genyk Y; Jhaveri V; Malogolowkin M; Mascarenhas L
Br J Surg; 2015 Jan; 102(1):108-13. PubMed ID: 25349947
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
